MedPath
NMPA Approval

Tetanus Antitoxin

国药准字S20247010

February 24, 2025

国药准字S10970021

Drug Information

破伤风抗毒素

注射剂

0.75ml,1500IU/支

生物制品

February 24, 2025

Company Information

Applicant Company

江西省吉安市井冈山经济技术开发区

Manufacturing Company

江西省吉安市井冈山经济技术开发区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

破伤风抗毒素 - NMPA 批准文号 | MedPath